Prevalence of three prothrombotic polymorphisms. Factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C 677T in Argentina. On behalf of the Grupo Cooperativo Argentino de Hemostasia y Trombosis.
Genoud
V
V
Facultad de Ciencias Exactas y Naturales. Dpto. Química Biológica, Laboratorio de Hemostasia y Trombosis, Universidad de Buenos Aires, Buenos Aires, Brazil.
Castañon
M
M
Annichino-Bizzacchi
J
J
Korin
J
J
Kordich
L
L
D000328:Adult; D000368:Aged; D001938:Brazil / Q000453:epidemiology; D005165:Factor V / Q000009:adverse effects / Q000235:genetics*; D005820:Genetic Testing; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008875:Middle Aged; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000009:adverse effects / Q000235:genetics*; D017354:Point Mutation; D011110:Polymorphism, Genetic / Q000235:genetics*; D015995:Prevalence; D011516:Prothrombin / Q000009:adverse effects / Q000235:genetics*; D012307:Risk Factors; D019851:Thrombophilia / Q000453:epidemiology / Q000235:genetics*
D005165:Factor V; D011516:Prothrombin; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)